false
0001604778
0001604778
2025-08-13
2025-08-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
August 13, 2025
(Date of earliest event reported)

Qorvo, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
001-36801 |
46-5288992 |
(State or Other Jurisdiction of
Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
7628 Thorndike Road, Greensboro, North Carolina
27409-9421
(Address of principal executive offices)
(Zip Code)
(336) 664-1233
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value |
|
QRVO |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As described under Item
5.07 below, at the Annual Meeting of Stockholders of Qorvo, Inc. (the “Company”) held on August 13, 2025 (the “Annual
Meeting”), the stockholders of the Company approved (i) the Qorvo, Inc. Amended and Restated 2022 Stock Incentive Plan (the “Amended
2022 Plan”) to increase the number of shares reserved for issuance thereunder by 3,240,000 shares of common stock of the Company
and (ii) the Qorvo Inc. Amended and Restated 2007 Employee Stock Purchase Plan (the “Amended 2007 Plan”) to increase the number
of shares reserved for issuance thereunder by 4,000,000 shares of common stock of the Company. The Board of Directors of the Company previously
approved the adoptions of the Amended 2022 Plan and Amended 2007 Plan, each subject to approval by the Company’s stockholders at
the Annual Meeting.
The principal features
of the Amended 2022 Plan and the Amended 2007 Plan are described in detail under “Proposal 3 – Approval of the Qorvo, Inc.
Amended and Restated 2022 Stock Incentive Plan” and “Proposal 4 – Approval of the Qorvo, Inc. Amended and Restated 2007
Employee Stock Purchase Plan,” respectively, of the Company’s 2025 Proxy Statement filed with the Securities and Exchange
Commission on June 26, 2025 (the “2025 Proxy Statement”), which descriptions are incorporated herein by reference.
The foregoing summaries
of the Amended 2022 Plan and Amended 2007 Plan do not purport to be complete and are subject to and qualified in their entirety by reference
to the text of the Amended 2022 Plan and Amended 2007 Plan, copies of which are included in the 2025 Proxy Statement as Appendix A and
Appendix B, respectively.
Item 5.07. Submission
of Matters to a Vote of Security Holders.
At the Annual Meeting,
the stockholders of the Company (i) elected each of the director nominees named in the 2025 Proxy Statement, (ii) approved, on an advisory
basis, the compensation of the Company’s named executive officers, (iii) approved the Amended 2022 Plan, (iv) approved the Amended
2007 Plan and (v) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm
for the fiscal year ending March 28, 2026. In addition, the Company’s stockholders did not approve a shareholder proposal
that was submitted at the Annual Meeting. The final voting results with respect to each of the proposals are set forth below.
Proposal 1. Stockholders elected
each of the ten directors below to serve a one-year term and until their respective successors are duly elected and qualified or until
their earlier resignation or removal.
Nominee |
Votes For |
Votes Against |
Abstain |
Broker Non-Votes |
Robert A. Bruggeworth |
72,692,641 |
631,278 |
1,368,940 |
6,697,987 |
Judy Bruner |
70,784,281 |
3,492,635 |
415,943 |
6,697,987 |
Richard L. Clemmer |
74,138,477 |
444,938 |
109,444 |
6,697,987 |
Peter A. Feld |
74,048,313 |
539,183 |
105,363 |
6,697,987 |
John R. Harding |
72,460,925 |
2,125,094 |
106,840 |
6,697,987 |
Christopher R. Koopmans |
74,381,242 |
204,489 |
107,128 |
6,697,987 |
Alan S. Lowe |
73,038,898 |
1,543,096 |
110,865 |
6,697,987 |
Roderick D. Nelson |
60,125,155 |
14,462,536 |
105,168 |
6,697,987 |
Dr. Walden C. Rhines |
69,677,214 |
4,908,238 |
107,407 |
6,697,987 |
Susan L. Spradley |
70,496,809 |
3,775,910 |
420,140 |
6,697,987 |
Proposal 2. Stockholders approved,
on an advisory basis, the compensation of the Company’s named executive officers.
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
44,106,958 |
|
30,466,498 |
|
119,403 |
|
6,697,987 |
Proposal 3. Stockholders approved the
Company’s Amended 2022 Plan.
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
69,017,396 |
|
4,307,090 |
|
1,368,373 |
|
6,697,987 |
Proposal
4. Stockholders approved the Company’s Amended 2007 Plan.
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
74,263,548 |
|
337,166 |
|
92,145 |
|
6,697,987 |
Proposal 5. Stockholders ratified the
appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending March
28, 2026.
For |
|
Against |
|
Abstain |
81,056,566 |
|
187,831 |
|
146,449 |
Proposal 6. Stockholders did not approve
a shareholder proposal submitted at the Annual Meeting.
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
32,855,372 |
|
41,715,004 |
|
122,483 |
|
6,697,987 |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Qorvo, Inc. |
|
|
|
|
By: |
/s/ Grant A. Brown |
|
|
Grant A. Brown |
|
|
Senior Vice President and Chief Financial Officer |
Date: August 15, 2025